Metraipolis › archive › dc_fe299ce146fd

PFKP in malignant tumors: bridging metabolic reprogramming, post-translational modifications, and the immunosuppressive microenvironment — Europe PMC PMID:42827624

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42827624
DOI: 10.3389/fcell.2026.1944968
License (as archived): solo-consultazione
Archived: 2026-10-08T06:10:01.136Z
SHA-256 of the archived text: 104d528f4ce7a020139fa34e439ca0e1ab6420b858218722c94ef05dccc4e1fc
Stable URL of this page: https://metraipolis.com/documento/dc_fe299ce146fd

How to cite

PFKP in malignant tumors: bridging metabolic reprogramming, post-translational modifications, and the immunosuppressive microenvironment — Europe PMC PMID:42827624 — Europe PMC (en), https://europepmc.org/article/MED/42827624 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe299ce146fd (Metraipolis archive dc_fe299ce146fd, sha256 104d528f4ce7a020139fa34e439ca0e1ab6420b858218722c94ef05dccc4e1fc)

BibTeX

@misc{dcfe299ce146fd,
  title = {PFKP in malignant tumors: bridging metabolic reprogramming, post-translational modifications, and the immunosuppressive microenvironment — Europe PMC PMID:42827624},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42827624},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe299ce146fd; sha256 104d528f4ce7a020139fa34e439ca0e1ab6420b858218722c94ef05dccc4e1fc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42827624. Agents can read the archived copy with the MCP tool read_document.